Skip to content

Effect of Celecoxib on Transitional Pain After Outpatient Surgery

Effect of Celecoxib on Transitional Pain After Outpatient Surgery

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00664690
Enrollment
0
Registered
2008-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2017-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

shoulder surgery, analgesia

Brief summary

Sixty adults having shoulder and forearm surgery will receive either placebo or celebrex started preoperatively and continued for 3 days. Rescue medications required as well as pain scores will be assessed using a patient diary to evaluate the effect of celebrex in controlling transitional pain

Interventions

DRUGcelebrex

400 mg celebrex given 1 hour preop and celebrex 200 mg BID postop

DRUGplacebo

placebo given preop and BID postop

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective ambulatory surgery of the shoulder * ASA I - III * Able to read English * Male or female

Exclusion criteria

* Allergy to local anesthetic, Cox2, sulpha drug, acetaminophen or oxycodone * Women who are pregnant or lactating and women of childbearing age and not following acceptable contraceptive precautions * Any major medical or psychiatric problem * Those with a known history of narcotic dependence, abuse or chronic narcotic intake * Patients with known history of peptic ulcer or GI bleeding in the past, ulcers, congestive heart failure, angina or previous heart attack, coagulation problems, venous thrombosis, kidney or liver disease or strokes

Design outcomes

Primary

MeasureTime frame
visual analogue score for painpost-op period

Secondary

MeasureTime frame
severity of nauseapost-op period

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026